Literature DB >> 9305410

What is an atypical antipsychotic?

G P Reynolds1.   

Abstract

This is an exciting time for research into the drug treatment of schizophrenia. Modern techniques in imaging and molecular biology have contributed to our understanding of the receptor mechanisms of antipsychotic drug action. Several new antipsychotics are, or will shortly be, available and each of these new drugs promise improvements over classical antipsychotics. This review will discuss the concept of atypicality in antipsychotic drugs, and will describe some of the models for identification of improved antipsychotic action. The various receptor mechanisms proposed to underlie atypical antipsychotic action, several of which have featured in recent debates in this journal, will be considered in the light of the pharmacology of some of the newly-emerging antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305410     DOI: 10.1177/026988119701100301

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  5 in total

1.  Atypicality of atypical antipsychotics.

Authors:  Andrew Farah
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 2.  Genetic predictors of therapeutic response to clozapine: current status of research.

Authors:  Dalu Mancama; Maria J Arranz; Robert W Kerwin
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.

Authors:  A Khullar; P Chue; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

Review 4.  Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies.

Authors:  Joseph H Porter; Adam J Prus
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

5.  Amisulpride is an "atypical" antipsychotic associated with low weight gain.

Authors:  Stefan Leucht; Stefan Wagenpfeil; Johannes Hamann; Werner Kissling
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.